Brokerages Set ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Target Price at $31.00
Shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) have received a consensus recommendation of “Buy” from the six research firms that are currently covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […]
Shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) have received a consensus recommendation of “Buy” from the six research firms that are currently covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […]
